Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Samuel Jacob Klempner, M.D.

Co-Author

This page shows the publications co-authored by Samuel Klempner and Aaron Hata.
Connection Strength

1.799
  1. Can the Help Match the Hype? KRASG12C-Specific Inhibitors and Beyond. Cancer Discov. 2020 01; 10(1):20-22.
    View in: PubMed
    Score: 0.875
  2. Sequence, Treat, Repeat: Addressing Resistance in EGFR-Mutant NSCLC. J Thorac Oncol. 2019 11; 14(11):1875-1877.
    View in: PubMed
    Score: 0.865
  3. Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation. Cancer Discov. 2021 Aug; 11(8):1913-1922.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.